IPOPEMA Securities (WAR:IPE) YoY EBITDA Growth: 300.00% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:IPE IPOPEMA Securities SA WAR:IPE
56 GF Score
Price zł9.30
GF Value zł3.63
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is IPOPEMA Securities YoY EBITDA Growth?

IPOPEMA Securities WAR:IPE -3.53% 56 YoY EBITDA Growth is 300.00% as of Mar. 2026. GuruFocus rates WAR:IPE with a GF Score™ of 56/100 and a GF Value™ of zł3.63 (Significantly Overvalued). The stock has 8 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. IPOPEMA Securities's YoY EBITDA Growth for the quarter that ended in Mar. 2026 was 300.00%.

IPOPEMA Securities's EBITDA per Share for the three months ended in Mar. 2026 was zł0.31.

IPOPEMA Securities YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for IPOPEMA Securities's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IPOPEMA Securities YoY EBITDA Growth Chart

IPOPEMA Securities Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -46.67 -33.92 111.45 -36.64 84.33

IPOPEMA Securities Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -48.67 11.15 58.18 365.84 300.00
WAR:IPE
56GF Score
IPOPEMA Securities SA WAR:IPE
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IPOPEMA Securities YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

IPOPEMA Securities's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(1.294-0.702)/ | 0.702 |
=84.33 %

IPOPEMA Securities's YoY EBITDA Growth for the quarter that ended in Mar. 2026 is calculated as:

YoY EBITDA Growth (Q: Mar. 2026 )
=(EBITDA per Share (Q: Mar. 2026 )-EBITDA per Share (Q: Mar. 2025 )) / | EBITDA per Share (Q: Mar. 2025 )) |
=(0.308-0.077)/ | 0.077 |
=300.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 300.00% mean?
IPOPEMA Securities (WAR:IPE) has a YoY EBITDA Growth of 300.00% as of Mar. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for IPOPEMA Securities and its competitors.
Is IPOPEMA Securities' YoY EBITDA Growth too high?
IPOPEMA Securities' current YoY EBITDA Growth is 300.00%. Overall, IPOPEMA Securities has a GF Score™ of 56/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does IPOPEMA Securities' YoY EBITDA Growth compare to MS and GS?
IPOPEMA Securities' YoY EBITDA Growth of 300.00% can be compared against companies in the Capital Markets industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Capital Markets company?
A good YoY EBITDA Growth depends on the Capital Markets industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for IPOPEMA Securities and its competitors. IPOPEMA Securities's current YoY EBITDA Growth is 300.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IPOPEMA Securities stock overvalued right now?
Based on GuruFocus' analysis, IPOPEMA Securities (WAR:IPE) is currently considered Significantly Overvalued. The stock's GF Value™ is zł3.63, compared to a current price of zł9.30 — trading 156.2% above its estimated fair value. The current YoY EBITDA Growth is 300.00%. IPOPEMA Securities' overall GF Score™ is 56/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For IPOPEMA Securities (WAR:IPE), the current YoY EBITDA Growth is 300.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IPOPEMA Securities (WAR:IPE) Overvalued in 2026?

Based on GuruFocus' analysis, IPOPEMA Securities stock appears to be overvalued. The current stock price of zł9.30 is trading 156.2% above its estimated GF Value™ of zł3.63. GuruFocus considers IPOPEMA Securities to be Significantly Overvalued.

Key valuation signals for WAR:IPE:

  • YoY EBITDA Growth: 300.00%
  • GF Value™: zł3.63 vs. price of zł9.30 (156.2% above fair value)
  • GF Score™: 56/100 with 8 warning signs

No single metric tells the full story. See the WAR:IPE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IPOPEMA Securities Business Description

Address 9 Prozna Street, Warsaw, POL, 00-107
IPOPEMA Securities SA is focused on brokerage activities, Business and management consulting, running an investment fund company and creating and managing investment funds, Management of portfolios of brokerage financial instruments, IT management activities, and IT consulting activities. It specializes in brokerage and company analysis services, investment banking services, as well as the distribution of investment products and investment advisory services addressed to a wide range of individual investors, the creation and management of closed-end and open-end investment funds and asset management, as well as business and IT consulting services.
56GF Score

Get the complete analysis for WAR:IPE

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł9.30
Price
zł3.63
GF Value